Work

Keystone Malaria Symposium 2022: a vibrant discussion of progress made and challenges ahead from drug discovery to treatment

Year: 2022

Type: review

Source: Trends in Parasitology

DOI: 10.1016/j.pt.2022.06.005

Authors: Mariko Kanai, Laura M. Hagenah, Elizabeth A. Ashley, Kelly Chibale, David A. Fidock

Institutions: Columbia University Irving Medical Center, Columbia University, Mahosot Hospital, University of Oxford, Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, South African Medical Research Council, University of Cape Town, Institute of Infectious Disease and Molecular Medicine

Language: English

Topic: Malaria Research and Control

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bill and Melinda Gates Foundation, Merck KGaA, Wellcome Trust, South African Medical Research Council, Medicines for Malaria Venture, Japan Student Services Organization, Tasmanian Institute of Agriculture, National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: Thailand Africa and Asia Programme - GBP Core, G1873888087, G1894600630, G2134833040, G3863397116, G392085450, G4589939456, G4664701975, G56945853, G5870538530, G5950055172, G6204766616, G6515210296, G6616342920, Columbia University - to develop state-of-the-art research platform to accelerate discovery of innovative medicines required for malaria elimination for the benefit of p..., G7188297838, Training Program in Microbiology for Infectious Diseases, Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance

OpenAlex ID: W4285735726

FWCI: 0.249

Cites: 31

Cited by: 4

Related to: 10